We conclude by highlighting the importance of increasing the M1-to-M2 ratio and the Th1-to-Th2 ratio to boost the anti-tumor immune response, in conjunction with a reduction of TGF-β-driven angiogenesis. The gene discussed is TGFB1; the disease is neoplasm.